SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Patel Bhavik

(Last)

(First)

(Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM

27703

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/07/2024

3. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	See Remarks

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	628⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Appreciation Right	⁽²⁾	02/10/2032	Common Stock	2,549	$250.43	D
Stock Appreciation Right	⁽³⁾	07/28/2032	Common Stock	1,740	$236.01	D
Stock Appreciation Right	⁽⁴⁾	02/13/2033	Common Stock	5,150	$232.11	D
Stock Appreciation Right	⁽⁵⁾	02/07/2034	Common Stock	6,906	$214.34	D

Explanation of Responses:

1. This amount includes 228 RSUs granted on February 10, 2022 which will vest on February 10, 2025 and 353 RSUs granted on July 28, 2022 which will vest in two annual installments beginning on July 28, 2024.

2. This stock appreciation right remains outstanding under the grant; 1,699 of which are currently vested; and 850 of which will vest on February 10, 2025.

3. This stock appreciation right remains outstanding under the grant; 580 of which are currently vested; and 1,160 of which will vest in two annual installments beginning on July 28, 2024.

4. This stock appreciation right remains outstanding under the grant; 1,716 of which are currently vested; and 3,434 of which will vest in two annual installments beginning on February 13, 2025.

5. The stock appreciation right vests in three annual installments beginning on February 7, 2025.

Remarks:

President, Commercial Solutions Power of Attorney

	/s/ Matthew Gilmartin, Attorney-in-Fact for Bhavik Patel	05/17/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.